Home /
The 7th webinar on Neonatal Technologies organized by the EPTRI Medical Devices Platform was held online on 17th September of 2024. In this webinar, which was a satellite event of the European Biotech Week, participants had the chance to learn more about the...
EPTRI has been implementing a Gender Equality Plan for 2024-2026, included in EPTRI’s Equality, Diversity and Inclusion strategy. This reaffirms its alignment with the 2030 Agenda and the Sustainable Development Goals. The Plan consists of 12 focus areas which aim...
We are happy to announce that our General Assembly and Scientific Meeting held on 18 and 19 of July in Bari, Italy and online were a success! We counted with about 250 participants both in person and online that learned about EPTRI's evolution story from a European...
The 6th webinar on Child Health Data and Artificial Intelligence organized by the EPTRI Medical Devices Platform was held online on 25th June of 2024. Participants had the chance to learn more about the impact of partnerships and co-design in shaping child health...
We are happy to announce our collaboration with Biogenera in their multi-center phase 1 clinical trial for the new orphan drug BGA002, intended for the treatment of aggressive pediatric tumors associated with alterations in the MYCN tumor gene. BIOGENERA has...
Our president, Karel Allegaert, participated in the paediatric committee (PDCO) scientific meeting related to the Belgian presidency that was held last week in Leuven. Related to the ongoing revision of the EMA guideline on neonatal clinical studies, Karel discussed...
The 5th webinar on Co-design in Child Health Technology organized by the EPTRI Medical Devices Platform was held online on 7th May of 2024. Participants had the chance to learn more about the impact of partnerships and co-design in shaping child health technology...
Donato Bonifazi and Adriana Ceci, both members of our Board of Directors, have co-authored the research paper entitled: “Innovative research methodologies in the EU regulatory framework: an analysis of EMA qualification procedures from a pediatric perspective”,...
Based on the current political developments in Europe and the formulation of a National Strategy for Rare Diseases there is a need to provide suitable therapeutic options to underserved populations such as paediatric population and people living with rare diseases....
On 19 March, the Committee on the Environment, Public Health and Food Safety (ENVI), as the committee responsible for the procedure, adopted its position on the new Directive and Regulation on medicinal products for human use. MEPs agreed on a number of...